Lamotrigine 100 MG Oral Tablet — RxCUI 198427
RxNorm drug concept · Semantic clinical drug
RxCUI 198427
Semantic clinical drug · SCD
● Current RxNorm concept 122 FDA products
309 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198427
Official nameLamotrigine 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped122
Package NDCs mapped309
Reported Medicaid activity (SDUD)4,065,515 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lamotrigine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- I completely understand the impatience — but the slow ramp-up is one of the most important safety steps with lamotrigine. Going too fast significantly raises your risk of a serious...
- Why does my doctor keep telling me to increase my dose so slowly? Can't we just get to the right dose faster?
- That's a fair question, and the honest answer is: with lamotrigine, we can't reliably tell in advance which rashes are harmless and which are dangerous. So the rule is — call your...
- What kind of rash should I worry about? I get skin reactions from all sorts of things.
🕸️ Concept Web — How Lamotrigine 100 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lamotrigine 100 MG Oral Tablet
RxCUI 198427 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Lamotrigine
28439IN
-
Lamotrigine
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lamictal
196502BN -
Subvenite
2001501BN
-
Lamictal
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lamotrigine Oral Tablet
372567SCDF -
Lamotrigine Oral Product
1162535SCDG -
Lamotrigine Pill
1162536SCDG -
Lamotrigine Oral Tablet [Lamictal]
368937SBDF -
Lamotrigine Oral Tablet [Subvenite]
2001503SBDF -
Lamictal Oral Product
1174986SBDG -
Lamictal Pill
1174987SBDG -
Subvenite Oral Product
2001504SBDG - +4 more in this family
-
Lamotrigine Oral Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lamotrigine 100 MG
316129SCDC -
Lamotrigine 100 MG Oral Tablet [Lamictal]
105018SBD -
Lamotrigine 100 MG Oral Tablet [Subvenite]
2003796SBD -
Lamotrigine 100 MG [Lamictal]
563872SBDC -
Lamotrigine 100 MG [Subvenite]
2003795SBDC
-
Lamotrigine 100 MG
-
Packs 6
Fixed collections of drugs packaged and sold together, like dose packs.
-
{14 (lamotrigine 100 MG Oral Tablet [Lamictal]) / 84 (lamotrigine 25 MG Oral Tablet [Lamictal]) } Pack [Lamictal Green (For Patients Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Rifampin and Not Taking Valproate)]
795778BPCK -
{14 (lamotrigine 100 MG Oral Tablet [Subvenite]) / 84 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Green (for Patients Taking Carbamazepine, Phenytoin, Phenobarbital, or Primidone and Not Taking Valproate)]
2003797BPCK -
{7 (lamotrigine 100 MG Oral Tablet [Lamictal]) / 42 (lamotrigine 25 MG Oral Tablet [Lamictal]) } Pack [Lamictal Orange (For Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Rifampin and Not Taking Valproate)]
795774BPCK -
{7 (lamotrigine 100 MG Oral Tablet [Subvenite]) / 42 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Orange (for Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Valproate)]
2003798BPCK -
{14 (lamotrigine 100 MG Oral Tablet) / 84 (lamotrigine 25 MG Oral Tablet) } Pack
753451GPCK -
{7 (lamotrigine 100 MG Oral Tablet) / 42 (lamotrigine 25 MG Oral Tablet) } Pack
751563GPCK
-
{14 (lamotrigine 100 MG Oral Tablet [Lamictal]) / 84 (lamotrigine 25 MG Oral Tablet [Lamictal]) } Pack [Lamictal Green (For Patients Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Rifampin and Not Taking Valproate)]
Showing up to 8 concepts per family — 22 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{14 (lamotrigine 100 MG Oral Tablet) / 84 (lamotrigine 25 MG Oral Tablet) } Pack
GPCK · 753451 -
{7 (lamotrigine 100 MG Oral Tablet) / 42 (lamotrigine 25 MG Oral Tablet) } Pack
GPCK · 751563 -
Lamotrigine 100 MG
SCDC · 316129 -
Lamotrigine Oral Tablet
SCDF · 372567 -
Lamotrigine Oral Product
SCDG · 1162535 -
Lamotrigine Pill
SCDG · 1162536
Brand-Name Concepts
-
Lamotrigine 100 MG Oral Tablet [Lamictal]
SBD · 105018 -
Lamotrigine 100 MG Oral Tablet [Subvenite]
SBD · 2003796 -
{14 (lamotrigine 100 MG Oral Tablet [Lamictal]) / 84 (lamotrigine 25 MG Oral Tablet [Lamictal]) } Pack [Lamictal Green (For Patients Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Rifampin and Not Taking Valproate)]
BPCK · 795778 -
{14 (lamotrigine 100 MG Oral Tablet [Subvenite]) / 84 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Green (for Patients Taking Carbamazepine, Phenytoin, Phenobarbital, or Primidone and Not Taking Valproate)]
BPCK · 2003797 -
{7 (lamotrigine 100 MG Oral Tablet [Lamictal]) / 42 (lamotrigine 25 MG Oral Tablet [Lamictal]) } Pack [Lamictal Orange (For Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Rifampin and Not Taking Valproate)]
BPCK · 795774 -
{7 (lamotrigine 100 MG Oral Tablet [Subvenite]) / 42 (lamotrigine 25 MG Oral Tablet [Subvenite]) } Pack [Subvenite Orange (for Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Valproate)]
BPCK · 2003798 -
Lamotrigine 100 MG [Lamictal]
SBDC · 563872 -
Lamotrigine 100 MG [Subvenite]
SBDC · 2003795 -
Lamotrigine Oral Tablet [Lamictal]
SBDF · 368937 -
Lamotrigine Oral Tablet [Subvenite]
SBDF · 2001503
📦 FDA Products & Package NDCs
122 products · 309 package NDCs
309 package NDCs map to RxCUI 198427 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 68382-0108-16 | 90 TABLET, CHEWABLE in 1 BOTTLE (68382-108-16) | Lamotrigine | Zydus Pharmaceuticals USA Inc. | 2009-01-23 |
| 68382-0109-01 | 100 TABLET, CHEWABLE in 1 BOTTLE (68382-109-01) | Lamotrigine | Zydus Pharmaceuticals USA Inc. | 2009-01-23 |
| 68382-0109-05 | 500 TABLET, CHEWABLE in 1 BOTTLE (68382-109-05) | Lamotrigine | Zydus Pharmaceuticals USA Inc. | 2009-01-23 |
| 68382-0109-16 | 90 TABLET, CHEWABLE in 1 BOTTLE (68382-109-16) | Lamotrigine | Zydus Pharmaceuticals USA Inc. | 2009-01-23 |
| 68788-7223-03 | 30 TABLET in 1 BOTTLE, PLASTIC (68788-7223-3) | Lamotrigine | Preferred Pharmaceuticals Inc. | 2018-07-26 |
| 68788-7223-06 | 60 TABLET in 1 BOTTLE, PLASTIC (68788-7223-6) | Lamotrigine | Preferred Pharmaceuticals Inc. | 2018-07-26 |
| 68788-7223-09 | 90 TABLET in 1 BOTTLE, PLASTIC (68788-7223-9) | Lamotrigine | Preferred Pharmaceuticals Inc. | 2018-07-26 |
| 68788-7871-03 | 30 TABLET in 1 BOTTLE (68788-7871-3) | Lamotrigine | Preferred Pharmaceuticals Inc. | 2021-02-15 |
| 68788-7871-06 | 60 TABLET in 1 BOTTLE (68788-7871-6) | Lamotrigine | Preferred Pharmaceuticals Inc. | 2021-02-15 |
| 68788-7871-09 | 90 TABLET in 1 BOTTLE (68788-7871-9) | Lamotrigine | Preferred Pharmaceuticals Inc. | 2021-02-15 |
| 69102-0137-10 | 7 BLISTER PACK in 1 PACKAGE, COMBINATION (69102-137-10) / 1... | LAMOTRIGINE Kit | OWP Pharmaceuticals, Inc. | 2017-08-30 |
| 69102-0150-06 | 100 TABLET in 1 BOTTLE (69102-150-06) | SUBVENITE | OWP Pharmaceuticals, Inc. | 2018-03-10 |
| 69102-0300-01 | 7 BLISTER PACK in 1 PACKAGE, COMBINATION (69102-300-01) / 1... | SUBVENITE | OWP Pharmaceuticals, Inc. | 2018-04-14 |
| 69102-0301-01 | 100 TABLET in 1 BOTTLE (69102-301-01) | SUBVENITE | OWP Pharmaceuticals, Inc. | 2018-03-10 |
| 69102-0301-02 | 6600 TABLET in 1 BOTTLE (69102-301-02) | SUBVENITE | OWP Pharmaceuticals, Inc. | 2018-03-10 |
| 69102-0306-01 | 35 BLISTER PACK in 1 BLISTER PACK (69102-306-01) / 1 KIT in... | SUBVENITE | OWP Pharmaceuticals, Inc. | 2018-04-14 |
| 69102-0312-01 | 14 BLISTER PACK in 1 PACKAGE, COMBINATION (69102-312-01) /... | SUBVENITE | OWP Pharmaceuticals, Inc. | 2018-04-14 |
| 69102-0319-01 | 100 TABLET in 1 BOTTLE (69102-319-01) | SUBVENITE | OWP Pharmaceuticals, Inc. | 2018-03-10 |
| 69102-0319-02 | 2500 TABLET in 1 BOTTLE (69102-319-02) | SUBVENITE | OWP Pharmaceuticals, Inc. | 2018-03-10 |
| 69102-0320-01 | 100 TABLET in 1 BOTTLE (69102-320-01) | SUBVENITE | OWP Pharmaceuticals, Inc. | 2018-03-10 |
| 69102-0359-11 | 14 BLISTER PACK in 1 PACKAGE, COMBINATION (69102-359-11) /... | LAMOTRIGINE Kit | OWP Pharmaceuticals, Inc. | 2017-08-30 |
| 69102-0639-09 | 35 TABLET in 1 DOSE PACK (69102-639-09) | LAMOTRIGINE | OWP Pharmaceuticals, Inc. | 2017-08-30 |
| 70518-2343-01 | 30 TABLET in 1 BLISTER PACK (70518-2343-1) | Lamotrigine | REMEDYREPACK INC. | 2025-08-06 |
| 70518-2563-00 | 30 TABLET in 1 BLISTER PACK (70518-2563-0) | Lamotrigine | REMEDYREPACK INC. | 2020-02-04 |
| 71205-0245-30 | 30 TABLET in 1 BOTTLE, PLASTIC (71205-245-30) | Lamotrigine | Proficient Rx LP | 2019-04-01 |
| 71205-0245-60 | 60 TABLET in 1 BOTTLE, PLASTIC (71205-245-60) | Lamotrigine | Proficient Rx LP | 2019-04-01 |
| 71205-0245-90 | 90 TABLET in 1 BOTTLE, PLASTIC (71205-245-90) | Lamotrigine | Proficient Rx LP | 2019-04-01 |
| 71335-0706-01 | 30 TABLET in 1 BOTTLE (71335-0706-1) | Lamotrigine | Bryant Ranch Prepack | 2018-02-22 |
| 71335-0706-02 | 60 TABLET in 1 BOTTLE (71335-0706-2) | Lamotrigine | Bryant Ranch Prepack | 2018-03-13 |
| 71335-0706-03 | 90 TABLET in 1 BOTTLE (71335-0706-3) | Lamotrigine | Bryant Ranch Prepack | 2019-10-08 |
| 71335-0706-04 | 120 TABLET in 1 BOTTLE (71335-0706-4) | Lamotrigine | Bryant Ranch Prepack | 2021-12-27 |
| 71335-0706-05 | 45 TABLET in 1 BOTTLE (71335-0706-5) | Lamotrigine | Bryant Ranch Prepack | 2021-12-27 |
| 71335-0706-06 | 180 TABLET in 1 BOTTLE (71335-0706-6) | Lamotrigine | Bryant Ranch Prepack | 2019-09-26 |
| 71335-0706-07 | 14 TABLET in 1 BOTTLE (71335-0706-7) | Lamotrigine | Bryant Ranch Prepack | 2019-10-24 |
| 71335-0706-08 | 100 TABLET in 1 BOTTLE (71335-0706-8) | Lamotrigine | Bryant Ranch Prepack | 2020-04-15 |
| 71335-2328-01 | 30 TABLET in 1 BOTTLE (71335-2328-1) | Lamotrigine | Bryant Ranch Prepack | 2024-01-09 |
| 71335-2328-02 | 60 TABLET in 1 BOTTLE (71335-2328-2) | Lamotrigine | Bryant Ranch Prepack | 2025-06-16 |
| 71335-2328-03 | 90 TABLET in 1 BOTTLE (71335-2328-3) | Lamotrigine | Bryant Ranch Prepack | 2024-01-02 |
| 71335-2328-04 | 120 TABLET in 1 BOTTLE (71335-2328-4) | Lamotrigine | Bryant Ranch Prepack | 2025-06-16 |
| 71335-2328-05 | 45 TABLET in 1 BOTTLE (71335-2328-5) | Lamotrigine | Bryant Ranch Prepack | 2025-06-16 |
| 71335-2328-06 | 180 TABLET in 1 BOTTLE (71335-2328-6) | Lamotrigine | Bryant Ranch Prepack | 2025-06-16 |
| 71335-2328-07 | 14 TABLET in 1 BOTTLE (71335-2328-7) | Lamotrigine | Bryant Ranch Prepack | 2025-06-16 |
| 71335-2328-08 | 100 TABLET in 1 BOTTLE (71335-2328-8) | Lamotrigine | Bryant Ranch Prepack | 2024-05-09 |
| 72789-0206-60 | 60 TABLET in 1 BOTTLE, PLASTIC (72789-206-60) | Lamotrigine | PD-Rx Pharmaceuticals, Inc. | 2021-09-27 |
| 72888-0025-00 | 1000 TABLET in 1 BOTTLE (72888-025-00) | Lamotrigine | Advagen Pharma Limited | 2021-10-29 |
| 72888-0025-01 | 100 TABLET in 1 BOTTLE (72888-025-01) | Lamotrigine | Advagen Pharma Limited | 2021-10-29 |
| 72888-0025-05 | 500 TABLET in 1 BOTTLE (72888-025-05) | Lamotrigine | Advagen Pharma Limited | 2021-10-29 |
| 72888-0026-00 | 1000 TABLET in 1 BOTTLE (72888-026-00) | Lamotrigine | Advagen Pharma Limited | 2021-10-29 |
| 72888-0026-01 | 100 TABLET in 1 BOTTLE (72888-026-01) | Lamotrigine | Advagen Pharma Limited | 2021-10-29 |
| 72888-0026-05 | 500 TABLET in 1 BOTTLE (72888-026-05) | Lamotrigine | Advagen Pharma Limited | 2021-10-29 |
Observed labelers:
Zydus Lifesciences Limited (28) ·
Zydus Pharmaceuticals USA Inc. (28) ·
Torrent Pharmaceuticals Limited (27) ·
Dr.Reddy's Laboratories Limited (20) ·
Sun Pharmaceutical Industries, Inc. (20) ·
GlaxoSmithKline LLC (18)
· +25 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.